Ab initio quantum mechanical study of the binding energies of human estrogen receptor ? with its ligands: An application of fragment molecular orbital method-Reference-Cited by-同舟云学术

Ab initio quantum mechanical study of the binding energies of human estrogen receptor ? with its ligands: An application of fragment molecular orbital method

Published:2004 Issue:1 Volume:26 Page:1-10
ISSN:0192-8651
Container-title:Journal of Computational Chemistry
language:en
Short-container-title:J. Comput. Chem.

Author:

Fukuzawa Kaori,Kitaura Kazuo,Uebayasi Masami,Nakata Kotoko,Kaminuma Tsuguchika,Nakano Tatsuya

Publisher

Wiley

Subject

Computational Mathematics,General Chemistry

Reference44 articles.

1. Cloning of a novel receptor expressed in rat prostate and ovary.

2. Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites

3. Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β

4. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β

5. Differential Response of Estrogen Receptor α and Estrogen Receptor β to Partial Estrogen Agonists/Antagonists

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction Analysis by Fragment Molecular Orbital Method for Drug Discovery Research;Chemical and Pharmaceutical Bulletin;2024-09-01

2. Computer-Aided Drug Design Using the Fragment Molecular Orbital Method: Current Status and Future Applications for SBDD;Chemical and Pharmaceutical Bulletin;2024-09-01

3. Combining the Fragment Molecular Orbital and GRID Approaches for the Prediction of Ligand–Metalloenzyme Binding Affinity: The Case Study of hCA II Inhibitors;Molecules;2024-07-30

4. Prediction of Binding Pose and Affinity of Nelfinavir, a SARS-CoV-2 Main Protease Repositioned Drug, by Combining Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations;The Journal of Physical Chemistry B;2024-03-04

5. Antibreast cancer oncological drugs;Quantum Chemistry Methods for Oncological Drugs;2024